{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:13:53Z","timestamp":1783480433903,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.mcna.2013.05.002","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T10:51:10Z","timestamp":1377859870000},"page":"857-872","source":"Crossref","is-referenced-by-count":24,"title":["Pathogenesis and Medical Management of Diabetic Charcot Neuroarthropathy"],"prefix":"10.1016","volume":"97","author":[{"given":"Janice V.","family":"Mascarenhas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Jude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2013.05.002_bib1","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2337\/dc11-0844","article-title":"The Charcot foot in diabetes","volume":"34","author":"Rogers","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2013.05.002_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1096-9136(199705)14:5<357::AID-DIA341>3.0.CO;2-8","article-title":"The natural history of acute Charcot\u2019s arthropathy in a diabetic foot specialty clinic","volume":"14","author":"Armstrong","year":"1997","journal-title":"Diabet Med"},{"key":"10.1016\/j.mcna.2013.05.002_bib3","series-title":"Charcot neuroarthropathy of the foot. Levin and O\u2019Neal\u2019s the diabetic foot","author":"Sanders","year":"2001"},{"key":"10.1016\/j.mcna.2013.05.002_bib4","series-title":"Hormones and disorders of mineral metabolism. Williams textbook of endocrinology","author":"Franklin","year":"2011"},{"key":"10.1016\/j.mcna.2013.05.002_bib5","series-title":"Metabolic bone disease. Williams textbook of endocrinology","author":"Joseph","year":"2011"},{"key":"10.1016\/j.mcna.2013.05.002_bib6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4049\/jimmunol.146.5.1541","article-title":"Lipopolysaccharide, tumor necrosis factor-\u03b1 and IL-1\u03b2 prevent programmed cell death (apoptosis) in human peripheral blood monocytes","volume":"146","author":"Mangan","year":"1991","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.mcna.2013.05.002_bib7","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.4049\/jimmunol.143.6.1801","article-title":"Calcium-dependent killing of immature thymocytes by stimulation via the CD3\/T cell receptor complex","volume":"143","author":"McConkey","year":"1989","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.mcna.2013.05.002_bib8","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0140-6736(05)67029-8","article-title":"The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes","volume":"366","author":"Jeffcoate","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2013.05.002_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2013.05.002_bib10","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2004.08.032","article-title":"Skeleton key to vascular disease","volume":"44","author":"Demer","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2013.05.002_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00005792-197205000-00006","article-title":"Neuro-arthropathy (Charcot joints) in diabetes mellitus: a clinical study of 101 cases","volume":"51","author":"Sinha","year":"1972","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.mcna.2013.05.002_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1359\/JBMR.041108","article-title":"Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity","volume":"20","author":"Offley","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.mcna.2013.05.002_bib13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1359\/jbmr.2000.15.3.474","article-title":"Decreased nitric oxide levels stimulate osteoclastogenesis and bone resorption both in\u00a0vitro and in\u00a0vivo on the chick chorioallantoic membrane in association with neoangiogenesis","volume":"15","author":"Collin-Osdoby","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.mcna.2013.05.002_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s007760050064","article-title":"Mechanotransduction and functional response of the skeleton to physical stress: the mechanisms and mechanics of bone adaptation","volume":"3","author":"Turner","year":"1998","journal-title":"J\u00a0Orthop Sci"},{"key":"10.1016\/j.mcna.2013.05.002_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0024-3205(97)00866-7","article-title":"Inhibition of LPS-induced TNF-\u03b1 production by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages","volume":"61","author":"Feng","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.mcna.2013.05.002_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/(SICI)1096-9136(199707)14:7<527::AID-DIA404>3.0.CO;2-Q","article-title":"Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy","volume":"14","author":"Gough","year":"1997","journal-title":"Diabet Med"},{"key":"10.1016\/j.mcna.2013.05.002_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/107110070502600109","article-title":"Current topics review: Charcot neuroarthropathy of the foot and ankle","volume":"26","author":"Trepman","year":"2005","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.mcna.2013.05.002_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3113\/FAI.2007.0952","article-title":"Current concepts review: Charcot arthropathy of the foot and ankle","volume":"28","author":"Pinzur","year":"2007","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.mcna.2013.05.002_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-2006-944525","article-title":"Charcot foot in diabetes: farewell to the neurotrophic theory","volume":"38","author":"Chantelau","year":"2006","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.mcna.2013.05.002_bib20","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2337\/diacare.14.8.750","article-title":"Body mass is a poor predictor of peak plantar pressure in diabetic men","volume":"14","author":"Cavanagh","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2013.05.002_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.jfas.2004.01.001","article-title":"Usefulness of a brief assessment battery for early detection of Charcot foot deformity in patients with diabetes","volume":"43","author":"Foltz","year":"2004","journal-title":"J\u00a0Foot Ankle Surg"},{"key":"10.1016\/j.mcna.2013.05.002_bib22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1359\/jbmr.070510","article-title":"Osteoporosis in patients with diabetes mellitus","volume":"22","author":"Hofbauer","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.mcna.2013.05.002_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.tp.0000244730.95416.c6","article-title":"High rate of Charcot foot attacks early after simultaneous pancreas-kidney transplantation","volume":"83","author":"Matricali","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.mcna.2013.05.002_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1067-2516(97)80072-5","article-title":"Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon","volume":"36","author":"Grant","year":"1997","journal-title":"J\u00a0Foot Ankle Surg"},{"key":"10.1016\/j.mcna.2013.05.002_bib25","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1359\/JBMR.050514","article-title":"Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone","volume":"20","author":"Kume","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.mcna.2013.05.002_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bone.2006.09.011","article-title":"Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways","volume":"40","author":"Alikhani","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.mcna.2013.05.002_bib27","first-page":"1315","article-title":"Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications","volume":"318","author":"Brownlee","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2013.05.002_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2337\/diab.45.3.S67","article-title":"The mechanism of collagen cross-linking in diabetes: a puzzle nearing resolution","volume":"45","author":"Monnier","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.mcna.2013.05.002_bib29","first-page":"529A","article-title":"Anatomical patterns of bone and joint destruction in neuropathic diabetics","volume":"40","author":"Sanders","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.mcna.2013.05.002_bib30","series-title":"The high risk foot in diabetes mellitus","first-page":"297","article-title":"Diabetic neuropathic osteoarthropathy: Charcot foot","author":"Sanders","year":"1991"},{"key":"10.1016\/j.mcna.2013.05.002_bib31","series-title":"The diabetic charcot foot: principles and management","first-page":"93","article-title":"Principles of conservative management","author":"Frykberg","year":"2010"},{"key":"10.1016\/j.mcna.2013.05.002_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1464-5491.2001.00511.x","article-title":"Calcaneal ultrasonomentry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover","volume":"18","author":"Jirkovska","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/j.mcna.2013.05.002_bib33","first-page":"409","article-title":"Magnetic resonance imaging in early stage charcot arthropathy; correlation of imaging findings and clinical symptoms","volume":"13","author":"Schlossbauer","year":"2008","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.mcna.2013.05.002_bib34","series-title":"Charcot joints","author":"Thomas","year":"1966"},{"key":"10.1016\/j.mcna.2013.05.002_bib35","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.2106\/00004623-199811000-00019","article-title":"Operative treatment of neuropathic arthropathy of the foot and ankle","volume":"80","author":"Johnson","year":"1998","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.mcna.2013.05.002_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2106\/00004623-199803000-00009","article-title":"Elevated peak plantar pressures in patients who have Charcot arthropathy","volume":"80","author":"Armstrong","year":"1998","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.mcna.2013.05.002_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-2007-970578","article-title":"Weight-bearing intensity produces charcot deformity in injured neuropathic feet in diabetes","volume":"115","author":"Kimmerle","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.mcna.2013.05.002_bib38","first-page":"317","article-title":"Monitoring healing of acute Charcot\u2019s arthropathy with infrared dermal thermometry","volume":"34","author":"Armstrong","year":"1997","journal-title":"J\u00a0Rehabil Res Dev"},{"key":"10.1016\/j.mcna.2013.05.002_bib39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0891-8422(23)00728-0","article-title":"Applications and use of in-shoe orthoses in the conservative management of Charcot foot deformity","volume":"11","author":"Giurini","year":"1994","journal-title":"Clin Podiatr Med Surg"},{"key":"10.1016\/j.mcna.2013.05.002_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1067-2516(07)60001-5","article-title":"Diabetic foot disorders. A clinical practice guideline (2006 revision)","volume":"45","author":"Frykberg","year":"2006","journal-title":"J\u00a0Foot Ankle Surg"},{"key":"10.1016\/j.mcna.2013.05.002_bib41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.mcna.2013.05.002_bib42","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1124\/mol.61.5.1255","article-title":"Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP\/ATP translocase by a nonhydrolyzable, adenine-containing metabolite","volume":"61","author":"Lehenkari","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.mcna.2013.05.002_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4161\/sgtp.2.3.16453","article-title":"The regulation of osteoclast function and bone resorption by small GTPases","volume":"2","author":"Itzstein","year":"2011","journal-title":"Small GTPases"},{"key":"10.1016\/j.mcna.2013.05.002_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.9-90004-3","article-title":"Bisphosphonates: preclinical review","volume":"9","author":"Green","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.mcna.2013.05.002_bib45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/er.19.1.80","article-title":"Bisphosphonates: mechanisms of action","volume":"19","author":"Fleisch","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.mcna.2013.05.002_bib46","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/jbmr.5650100617","article-title":"Interleukin-6 and the acute phase response during treatment of patients with Paget\u2019s disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate","volume":"10","author":"Schweitzer","year":"1995","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.mcna.2013.05.002_bib47","doi-asserted-by":"crossref","first-page":"8528","DOI":"10.1200\/jco.2006.24.18_suppl.8528","article-title":"Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy","volume":"24","author":"Hoff","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.mcna.2013.05.002_bib48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1464-5491.1994.tb00225.x","article-title":"Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy?","volume":"11","author":"Selby","year":"1994","journal-title":"Diabet Med"},{"key":"10.1016\/j.mcna.2013.05.002_bib49","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s001250100008","article-title":"Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial","volume":"44","author":"Jude","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.mcna.2013.05.002_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.jfas.2004.07.005","article-title":"Bisphosphonates for the treatment of Charcot neuroarthropathy","volume":"43","author":"Anderson","year":"2004","journal-title":"J\u00a0Foot Ankle Surg"},{"key":"10.1016\/j.mcna.2013.05.002_bib51","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/diacare.28.5.1214","article-title":"Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial","volume":"28","author":"Pitocco","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2013.05.002_bib52","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S8756-3282(02)00688-9","article-title":"Forty years of calcitonin\u2014where are we now? A tribute to the work of Iain Macintyre, FRS","volume":"30","author":"Zaidi","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.mcna.2013.05.002_bib53","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/jm00005a011","article-title":"Structural and conformational requirements for human calcitonin activity. Design, synthesis and study of lactam bridge analogs","volume":"38","author":"Kapurniato","year":"1995","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.mcna.2013.05.002_bib54","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2337\/dc06-0376","article-title":"Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial","volume":"29","author":"Bem","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2013.05.002_bib55","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/107110070602701007","article-title":"Cytokine-induced osteoclastic bone resorption in Charcot arthropathy: an immunohistochemical study","volume":"27","author":"Baumhauer","year":"2006","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.mcna.2013.05.002_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/art.27227","volume":"62","author":"Hetland","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mcna.2013.05.002_bib57","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJMct055183","article-title":"Tumor necrosis factor inhibitors for rheumatoid arthritis","volume":"355","author":"Scott","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2013.05.002_bib58","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.20217","volume":"50","author":"Keystone","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mcna.2013.05.002_bib59","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/art.21655","article-title":"Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial","volume":"54","author":"van der Heijde","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mcna.2013.05.002_bib60","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2013.05.002_bib61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2796.2010.02313.x","article-title":"Blocking interleukin-1\u03b2 in acute and chronic autoinflammatory diseases","volume":"269","author":"Dinarello","year":"2011","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.mcna.2013.05.002_bib62","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/ard.2003.016014","article-title":"A\u00a0multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin\u00a01 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate","volume":"63","author":"Cohen","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mcna.2013.05.002_bib63","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","article-title":"Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mcna.2013.05.002_bib64","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N\u00a0Engl J Med"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712513000710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712513000710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:11:50Z","timestamp":1715951510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712513000710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0025712513000710"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2013.05.002","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}